Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone sodium phosphate + povidone-iodine + isopropyl alcohol + lidocaine
- Development stage
- Unknown
- Lead developer
- Enovachem
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular, Topical
01
Overview
Dexlido is a multi-component pharmaceutical kit containing dexamethasone sodium phosphate injection, lidocaine injection, povidone-iodine swabsticks, and 70% isopropyl alcohol prep pads. The therapeutic core of the product is dexamethasone sodium phosphate, a water-soluble synthetic glucocorticoid corticosteroid that activates the glucocorticoid receptor to produce anti-inflammatory and immunosuppressive effects; lidocaine provides local anesthetic activity via blockade of voltage-gated sodium channels, while povidone-iodine and isopropyl alcohol function as topical antiseptic skin-preparation components. The product has been distributed by Enovachem Pharmaceuticals and appears to be positioned as a procedure/injection kit rather than a novel molecular entity. Based on the provided context, it is an unapproved drug product whose labeling has not been approved by the FDA.
- Brand names
- Dexlido
- Other names
- Dexlido Kit
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on dexamethasone sodium phosphate + povidone-iodine + isopropyl alcohol + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone sodium phosphate + povidone-iodine + isopropyl alcohol + lidocaine.